Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Nutrition|January 30, 2004
Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjectsB A Parker, K Sturm, C G MacIntosh, et al.
Leukemia|October 10, 1998
Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemiaS L Soignet, F Benedetti, A Fleischauer, et al.
Cell Cycle (Georgetown, Tex.)|May 8, 2015
Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristicsA Parish, M Schwaederle, G Daniels, et al.
Blood|May 1, 1996
Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodiesC A White, S E Halpern, B A Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B studyB A Parker, M Santarelli, M R Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550)S L Soignet, V A Miller, D G Pfister, et al.
Cancer Research|February 1, 1990
Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibodyB A Parker, A B Vassos, S E Halpern, et al.
Cancer|July 24, 2001
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854N L Bartlett, G R Petroni, B A Parker, et al.
Clinical Pharmacology and Therapeutics|March 25, 2011
Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomesL Madlensky, L Natarajan, S Tchu, et al.
Breast Cancer Research and Treatment|December 23, 2016
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcomeA H M de Vries Schultink, X Alexi, E van Werkhoven, et al.
Pageof 3